Drug Name Antiarrhythmic Classification Use & Avoidance Previous FDA Category Neonatal/Fetal Adverse Effects Placental Transfer Transfer to Breast Milk Quinidine procainamide Class IA Ventricular and supraventricular arrhythmias. Procainamide effect for SVT in pre-excitation. Avoid quinidine during breastfeeding. Quinidine needs frequent monitoring to avoid drug toxicity. C Quinidine: Accumulation in neonatal liver. Otherwise no teratogenicity. Procainamide: minima data available Yes Yes Lidocaine Class IB Cardiac arrest (As per ACLS guidelines) and ventricular arrhythmias Lidocaine levels need frequent monitoring. Considerably safe in pregnancy. B Cardiac, vascular, and neurologic effects however some studies show normal perinatal course Yes Yes Mexiletine Class IB Ventricular arrhythmias. Only used if refractory to other medical management. Mexiletine levels need frequent monitoring. C Limited studies; animal studies show adverse fetal effects Yes Yes Flecainide Class 1C Supraventricular and ventricular arrhythmias. Lowest dose possible. Considerably safe in pregnancy. C Limited studies; animal studies without teratogenic effects Yes Yes Propafenone Class 1C Supraventricular and ventricular arrhythmias Not assigned Limited data; no adverse fetal effects noted in multiple case reports Yes Yes Beta-blockers (propranolol, metoprolol, carvedilol, atenolol) Class II Metoprolol/propranolol: Ventricular and supraventricular arrhythmias, atrial fibrillation/flutter Metoprolol/carvedilol: GDMT for PPCM Preferred: metoprolol, propranolol, sotalol, nadolol, pindolol. Avoid atenolol during pregnancy and during breastfeeding. C Hypoglycemia, bradycardia, respiratory depression, fetal growth retardation, hypotension Yes Yes Sotalol Class II and III Ventricular and supraventricular arrhythmias, atrial fibrillation/flutter. Considerably safe in pregnancy and during breastfeeding. B Fetal bradycardia and hypoglycemia Yes Yes Amiodarone Class III Ventricular and supraventricular arrhythmias, atrial fibrillation/flutter. Consider as last line, only if refractory to other medical management. Use minimal dose and for shortest duration possible. D Neonatal bradycardia, QTc prolongation, fetal growth restriction, fetal hypothyroidism, neurodevelopmental abnormalities, ventricular extrasystoles Yes Yes Dofetilide Class III Rhythm control in atrial fibrillation/flutter or supraventricular arrhythmias. Not recommended for use in pregnancy given limited data C Minimal data available. Skeletal abnormalities and bradycardia Unknown Unknown Calcium channel blockers (verapamil, diltiazem) Class IV Supraventricular tachycardia, atrial fibrillation/flutter Verapamil recommended over diltiazem. C Decreased neonatal birth weight, increased preterm delivery, bradycardia Diltiazem: fetal death/stillbirth Yes Yes Digoxin Glycoside agent, Supraventricular tachyarrhythmias, atrial fibrillation/flutter. Considerably safe in pregnancy and during breastfeeding. Digoxin levels need frequent monitoring. C No noted teratogenicity. Digoxin toxicity in neonates manifests as vomiting or cardiac arrhythmias Yes Yes Ivabradine Inhibits If channels in the sinoatrial node Heart failure and intolerance to beta-blockers, inappropriate sinus tachycardia. Contraindicated in pregnancy and during breastfeeding. Not assigned Severe fetal bradycardia in fetus, cardiac malformations, retinal toxicity, intrauterine mortality Unknown Unknown